Milliman MedInsight (R) (MedInsight), a leading healthcare data and analytics division of Milliman, is entering 2026 with accelerating momentum in value-based care. Milliman MedInsight has earned ...

A pattern quickly emerged after speaking to clinical data executives at events in Basel, New York, London, and Copenhagen. Although thousands of miles apart, the focus on simplifying and standardizing ...

Healthcare providers receive data from many disparate sources: hospitals, doctors’ offices, labs and lab machines, medical devices, pharmacies, and more. Investment in the correct infrastructure to ...

NEW YORK--(BUSINESS WIRE)--Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, today announced new experiences for enhancing and ...

Mergers and acquisitions (M&As) are highly prevalent in the healthcare industry—a trend that will likely continue into the foreseeable future. The first half of 2024 saw 31 announced hospital M&As, ...

Managing non-EDC (Electronic Data Capture) data integration in clinical trials is a challenge that holds significant promise. As clinical studies continue to draw on data from wearable devices like ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Healthcare data streams continue to increase exponentially thanks to the ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

Sharing data after a clinical trial has been completed seems like it should be a slam dunk, a win for many stakeholders, including the general public. Instead, such data sharing is still something of ...

It is now a commonplace to propose high-dimensional molecular characterization within the translational research objectives of contemporary clinical trials. Similarly, most of these methods are being ...